Sourced fact
The News
According to The Times of Israel, Turkey's Competition Authority has opened an investigation against Israeli pharmaceutical giant Teva on allegations that it impedes competitors from entering the market.
Analysis & context
Analysis & Context
Analytically, this investigation is part of the growing global efforts to ensure fair competition in the pharmaceutical market. In a broader context, major pharmaceutical companies like Teva are facing increasing allegations of using illegitimate means to prevent competitors from entering the market, impacting drug prices and accessibility. This step by Turkey's Competition Authority underscores a greater commitment to tightening oversight on large corporations in this sensitive sector.
